je.st
news
Tag: drug
Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine
2016-08-05 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Marketing Authorization Application to the European Medicines Agency Currently Under Review KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for MK-1293, an investigational follow-on biologic1 insulin glargine candidate for the treatment of people with type 1 and type 2 diabetes, which is being developed by Merck with partial funding from Samsung Bioepis. Language: English Contact: MerckMedia:Doris Li, 908-246-5701orKristen Drake, 908-236-4223orInvestors:Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
drug
acceptance
filing
05/04/12 -- Oral Fluid Drug Test Includes Four Drugs To Address Changing Abuse
2016-06-13 18:59:24| drugdiscoveryonline News Articles
05/04/12 Drug Discovery Online Newsletter
Tags: address
includes
test
abuse
06.01.12 -- FDA-Approved Drug Makes Established Cancer Vaccine Work Better
2016-06-13 18:59:24| drugdiscoveryonline News Articles
06/01/12 Drug Discovery Online Newsletter
Tags: work
better
makes
established
The Challenges Of Demand Forecast Accuracy For New Drug Launches
2016-06-13 11:39:02| drugdiscoveryonline Downloads
This webinar discusses how achievingaccurate demand forecasts is extremely challenging, especially for new drug launches, and what other pharmaceutical companies are doing to overcome those challenges.
Tags: drug
accuracy
demand
challenges
Impact Of Incorrect Forecasts On New Drug Product Launches
2016-06-10 17:34:44| drugdiscoveryonline Home Page
Pharmaceutical companies around the world are under tremendous pressure – from regulators, legislators, payers, and patients – to reduce the cost of drugs. In response to the outcry for cost-cutting, pharmaceutical company leaders are examining every aspect of their business to determine where they can derive savings, particularly when planning for the launch of a new product. Pharmaceutical company marketing executives have become more accurate in positioning their new product in the marketplace, profiling prescribers, and understanding and responding to the reimbursement landscape. What is still a quagmire for pharma companies is predicting the actual demand for products and the timing of that demand.
Tags: product
impact
drug
incorrect
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »